Susan Carpenter

Susan Carpenter has extensive experience in clinical development, currently serving as the Director of Clinical Development at Harpoon Therapeutics since July 2022. Prior roles include Sr. Clinical Scientist at Bristol Myers Squibb and Director of Clinical Operations at Aptose Biosciences, managing early-stage drug development programs focused on various critical aspects such as site selection, patient enrollment, and data preparation. Susan's career in clinical services at Eli Lilly and Company and leadership in clinical development at Peregrine Pharmaceuticals and Allergan further showcase expertise in delivering drug development programs efficiently. Academically, Susan holds a PhD in Toxicology with a focus on Pharmaceutical Sciences from The University of New Mexico and a BS/BA in Biology and Chemistry from New Mexico State University.